Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue

Arthritis and Rheumatism

Volumn 41, Issue 9, 1998, Pages 1689-1694

  Sprott, Haiko ^a,b   Bradley, Laurence A ^b   Oh, Shin J ^b   Wintersberger, Winfried ^b   Alarcón, Graciela S ^b   Mussell, Holly G ^b   Tseng, Anna ^b   Gay, Renate E ^b,c   Gay, Steffen ^b,c,d  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NEUROPEPTIDE; SECRETONEURIN; SEROTONIN; SUBSTANCE P;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROMYALGIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; DNA PRIMERS; FEMALE; FIBROMYALGIA; GALANIN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SECRETOGRANIN II; SEROTONIN; SUBSTANCE P;

EID: 0031684344     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199809)41:9<1689::AID-ART21>3.0.CO;2-X     Document Type: Article

References (40)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 1990;33:160-72.
2. Elam M, Johansson G, Wallin BG. Do patients with primary fibromyalgia have an altered muscle sympathetic nerve activity? Pain 1992;48:371-5.
3. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 1993;5:199-208.
4. Bengtsson A, Henriksson KG. Fibromyalgins orsaker bade perifera och centrala. [Causes of fibromyalgia are both peripheral and central.] Lakartidningen 1996;93:161-3.
5. Granges G, Littlejohn GO. A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumatol 1993;20:344-51.
6. Granges G, Littlejohn G. Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 1993;36: 642-6.
7. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women: abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38:926-38.
8. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated ccrebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum 1994;37:1593-601.
9. Murphy RM, Zemlan FP. Differential effects of substance P on serotonin-modulated spinal nociceptive reflexes. Psychopharmacology (Berl) 1987;93:118-21.
10. Mathias BJ, Dillingham TR, Zeigler DN, Chang AS, Belandres PV. Topical capsaicin for chronic neck pain: a pilot study. Am J Phys Med Rehabil 1995;74:39-44.
11. Evans HF, Shine J. Human galanin: molecular cloning reveals a unique structure. Endocrinology 1991;129:1682-4.
12. Wiesenfeld-Hallin Z, Bartfai T, Hokfelt T. Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol 1992;13:319-43.
13. Reimann W, Englberger W, Friderichs E, Selve N, Wilffert B. Spinal antinociception by morphine in rats is antagonised by galanin receptor antagonists. Naunyn Schmiedebergs Arch Pharmacol 1994;350:380-6.
14. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993;365:170-5.
15. Mulder H, Uddman R, Moller K, Zhang YZ, Ekblad E, Alumets J, et al. Pituitary adenylate cyclase activating polypeptide expression in sensory neurons. Neuroscience 1994;63:307-12.
16. Yamamoto T, Tatsuno I. Antinociceptive effect of intrathecally administered pituitary adenylate cyclase activating polypeptide (PACAP) on the rat formalin test. Neurosci Lett 1995;184:32-5.
17. Schürmann G, Bishop AE, Facer P, Eder U, Fischer-Colbrie R, Winkler H, et al. Secretoneurin: a new peptide in the human enteric nervous system. Histochem Cell Biol 1995;104:11-9.
18. Marksteiner J, Mahata SK, Pycha R, Mahata M, Saria A, Fischer-Colbrie R, et al. Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparison with that of substance P and calcitonin gene-related peptide. J Comp Neurol 1994;340:243-54.
19. Telser S, Marksteiner J, Hinterhuber H, Saria A. Distribution of secretoneurin-like immunoreactivity in comparison with that of substance P in the human spinal cord. Neurosci Lett 1995;191: 83-6.
20. Tadaki N, Hisa Y, Uno T, Koike S, Okamura H, Ibata Y. Neurotransmitters for the canine inferior pharyngeal constrictor muscle. Otolaryngol Head Neck Surg 1995;113:755-9.
21. Li JY, Hou XE, Dahlstrom A. GAP-43 and its relation to autonomic and sensory neurons in sciatic nerve and gastrocnemius muscle in the rat. J Auton Nerv Syst 1995;50:299-309.
22. Aaron LA, Bradley LA, Alarcón GS, Alexander RW, Triana-Alexander M, Martin MY, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996;39:436-45.
23. Dubowitz V, editor. Muscle biopsy, a practical approach. London: Bailliere Tindall; 1985.
24. Puissant C, Houdebine L. An improvement of the single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 1991;8:148-9.
25. Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, Mayaux JF. Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci U S A 1994;91:9780-3.
26. Müller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S. Demonstration of granzyme A and perform messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
27. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 1993; 53:359-66.
28. Kriegsmann J, Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S. Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-14.
29. Vaeroy H, Sakurada T, Forre O, Kass E, Terenius L. Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol 1989;19 Suppl:94-7.
30. Hrycaj P, Stratz T, Müller W. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome [letter]. J Rheumatol 1993;20: 1986-8.
31. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J. Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 1991;12:333-7.
32. Moskowitz MA. Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 1993;43 Suppl 3:S16-20.
33. Jones PM, Ghatei MA, Steel J, O'Halloran D, Gon G, Legon S, et al. Evidence for neuropeptide Y synthesis in the rat anterior pituitary and the influence of thyroid hormone status: comparison with vasoactive intestinal peptide, substance P, and neurotensin. Endocrinology 1989;125:334-41.
34. Ohlen A, Wiklund NP, Persson MG, Hedqvist P. Calcitonin gene-related peptide desensitizes skeletal muscle arterioles to substance P in vivo. Br J Pharmacol 1988;95:673-4.
35. Mayer EA, Raybould H, Koelbel C. Neuropeptides, inflammation, and motility. Dig Dis Sci 1988;33 Suppl 3:71S-7S.
36. Perrin LF, Laurent PE. Asthma and neuropeptides. Eur J Med 1993;2:164-9.
37. Sluka KA. Pain mechanisms involved in musculoskeletal disorders. J Orthop Sports Phys Ther 1996;24:240-54.
38. Takeba Y, Suzuki N, Asai T, Tsuboi S, Sakane T. Modulation by neuropeptides of synovial cell functions in human rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S248.
39. Lapadula G, Iannone F, Acquista CA, De Bari C, Grattagliano V, Covelli M, et al. Increased expression of neuropeptides by osteoarthritic human articular chondrocytes [abstract]. Arthritis Rheum 1996;39 Suppl 9:S269.
40. Yunus MB, Kalyan-Raman UP, Masi AT, Aldag JC. Electron microscopic studies of muscle biopsy in primary fibromyalgia syndrome: a controlled and blinded study. J Rheumatol 1989;16: 97-101.